Pfizer to govt: Vaccine highly effective on variant prevalent in India

US pharma giant Pfizer on Wednesday told the central government that its Covid-19 vaccine is "highly effective" against the Covid-19 variant that is prevalent in India. Pfizer has also reportedly sought fast-track approval of its vaccine.

In a report, PTI said Pfizer presented data and told Indian authorities that its vaccine has shown "high effectiveness" against the variant prevalent in India and on people of Indian ethnicity or nationality.

Besides this, Pfizer added that its vaccine is also suitable for everyone aged 12 years or above and can be stored for a month at 2-8 degrees.

Watch this video to know more.